208 related articles for article (PubMed ID: 36106103)
1. Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer.
Tang H; Shan J; Liu J; Wang X; Wang F; Han S; Zhao X; Wang J
Front Oncol; 2022; 12():995929. PubMed ID: 36106103
[TBL] [Abstract][Full Text] [Related]
2. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
3. Molecular Features, Prognostic Value, and Cancer Immune Interactions of Angiogenesis-Related Genes in Ovarian Cancer.
Ji Y; Ge Q; Zhang W; Qu P
Reprod Sci; 2023 May; 30(5):1637-1650. PubMed ID: 36471217
[TBL] [Abstract][Full Text] [Related]
4. Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer.
Zhang C; Liu T; Yun Z; Liang B; Li X; Zhang J
Front Pharmacol; 2023; 14():1103547. PubMed ID: 36909170
[No Abstract] [Full Text] [Related]
5. Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma.
Cui G; Liu J; Wang M; Shon K; Wang C; Wei F; Sun Z
Front Immunol; 2022; 13():1049485. PubMed ID: 36505481
[TBL] [Abstract][Full Text] [Related]
6. Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer.
Geng R; Zhong Z; Ni S; Liu W; He Z; Gan S; Huang Q; Yu H; Bai J; Liu J
Oxid Med Cell Longev; 2023; 2023():4945288. PubMed ID: 37082103
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer.
Wang Y; Li BX; Li X
Front Oncol; 2021; 11():783666. PubMed ID: 35047401
[TBL] [Abstract][Full Text] [Related]
8. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma.
Hu T; Wang Y; Wang X; Wang R; Song Y; Zhang L; Han S
Front Genet; 2022; 13():934683. PubMed ID: 36035133
[No Abstract] [Full Text] [Related]
10. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
11. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
12. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
13. A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer.
Ge W; Shentu D; Wang Y; Wang Y; Xue S; Yue M; Mao T; Zhang X; Xu H; Li S; Ma J; Yao J; Cui J; Wang L
Front Cell Dev Biol; 2022; 10():1001606. PubMed ID: 36274838
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
15. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk of Redox-Related Subtypes, Establishment of a Prognostic Model and Immune Responses in Endometrial Carcinoma.
Geng R; Song J; Zhong Z; Ni S; Liu W; He Z; Gan S; Huang Q; Yu H; Bai J; Liu J
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884444
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
18. Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment.
Sun D; Zhao X; Yu Y; Li W; Gu P; Zhi Z; Xu D
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35137909
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
[TBL] [Abstract][Full Text] [Related]
20. Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer.
Zhou M; Li B; Liu J; Hong L
J Inflamm Res; 2021; 14():7341-7358. PubMed ID: 34992421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
